Tilray Brands (TLRY) Cash from Financing Activities (2017 - 2026)

Tilray Brands (TLRY) reported Cash from Financing Activities of -$5.1 million for Q1 2026, down 128.38% on a YoY basis from $18.1 million in Q1 2025, and down 110.66% quarter-over-quarter from $48.1 million in Q4 2025.

Tilray Brands (TLRY) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Tilray Brands has reported Cash from Financing Activities for 10 years, with the latest figure at -$5.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 128.38% year-over-year to -$5.1 million; the trailing twelve-month figure through Feb 2026 stood at $79.5 million (down 35.88% YoY), and the FY2025 full-year result was $133.5 million, up 277.57% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$5.1 million, down from $48.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $161.8 million in Q2 2022, with the low at -$85.4 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $20.4 million across 5 years, with a median of $14.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 1639.86% — and 2024, when it slumped 346.72%.
  • Tilray Brands' Cash from Financing Activities stood at -$57.3 million in 2022, then tumbled by 49.1% to -$85.4 million in 2023, then surged by 144.75% to $38.2 million in 2024, then increased by 25.91% to $48.1 million in 2025, then plunged by 110.66% to -$5.1 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$5.1 million (Q1 2026), $48.1 million (Q4 2025), and $19.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Tilray Brands - - 54.95 Mn -5.13 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -5.13 Mn
Feb 28, 2026 -5.13 Mn
Nov 30, 2025 48.10 Mn
Nov 30, 2025 48.10 Mn
Aug 31, 2025 19.85 Mn
Aug 31, 2025 19.85 Mn
May 31, 2025 16.64 Mn
May 31, 2025 16.64 Mn
Feb 28, 2025 18.07 Mn
Feb 28, 2025 18.07 Mn
Nov 30, 2024 38.20 Mn
Nov 30, 2024 38.20 Mn
Aug 31, 2024 60.59 Mn
Aug 31, 2024 60.59 Mn
May 31, 2024 7.07 Mn
May 31, 2024 7.07 Mn
Feb 29, 2024 -10.91 Mn
Feb 29, 2024 -10.91 Mn
Nov 30, 2023 -85.37 Mn
Nov 30, 2023 -85.37 Mn